Iressa 250 mg Tablet
  1. Home
  2. Pharma Products
  3. AstraZeneca Pharma India Ltd
  4. Iressa 250 mg Tablet

Iressa 250 mg Tablet

Iressa 250 mg Tablet contains gefitinib, a targeted anticancer medicine used to treat certain types of non-small cell lung cancer. Each tablet contains 250 mg of gefitinib and is taken orally as prescribed by a specialist. It works by blocking EGFR signaling involved in the growth of certain lung cancer cells.

BUY NOW

Category

Gefitinib is an EGFR tyrosine kinase inhibitor that targets specific activating EGFR mutations in eligible patients with non-small cell lung cancer. By inhibiting abnormal EGFR signaling, it can help slow the growth and spread of cancer cells. Iressa is generally used as monotherapy in adults with locally advanced or metastatic non-small cell lung cancer with activating EGFR mutations. Treatment should be initiated and supervised by a physician experienced in anticancer therapy.

Technical Specification

Specification Details
Active Ingredient Gefitinib
Strength 250 mg
Dosage Form Film-Coated Tablet
Route of Administration Oral
Pack Size 30 Tablets
Manufacturer/Marketer AstraZeneca Pharma India Ltd

Product Also Known As

Iressa 250 mg Tablet, Gefitinib 250 mg Tablet, Iressa Gefitinib Tablet, Gefitinib Anticancer Tablet, EGFR Inhibitor Tablet, Non-Small Cell Lung Cancer Treatment Tablet

Related products